Onconetix annual operating margin
2023
2024
2025
Onconetix's operating margin was −2,190.03% for fiscal 2025.
View full Onconetix company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −2,190.03% | +47.93 pp |
| 2024 | 2024-12-31 | −2,237.96% | +59396.51 pp |
| 2023 | 2023-12-31 | −61,634.47% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −15,950.88% | −14133.48 pp |
| Q1 2026 | 2026-03-31 | −47,657.18% | −35287.97 pp |
| Q4 2025 | 2025-12-31 | −422.06% | +3671.60 pp |
| Q3 2025 | 2025-09-30 | −681.45% | −31.14 pp |
| Q2 2025 | 2025-06-30 | −1,817.40% | +114.23 pp |
| Q1 2025 | 2025-03-31 | −12,369.21% | −10787.05 pp |
| Q4 2024 | 2024-12-31 | −4,093.66% | — |
| Q3 2024 | 2024-09-30 | −650.32% | — |
| Q2 2024 | 2024-06-30 | −1,931.62% | — |
| Q1 2024 | 2024-03-31 | −1,582.16% | — |
Across the available reported history, Onconetix's operating margin increased from −2,237.96% to −2,190.03%, a change of +47.93 percentage points. The latest reported quarter, Q2 2026, shows −15,950.88%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Onconetix filings at SEC.gov ↗